ACOR

Acorda Therapeutics

Delisted

ACOR was delisted on the 11th of April, 2024.

167 hedge funds and large institutions have $1.01B invested in Acorda Therapeutics in 2016 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 58 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$14.5M
Puts
$21.5M
Net Calls
Net Calls Change

Top Buyers

1 +$21.6M
2 +$12.6M
3 +$11.4M
4
Citadel Advisors
Citadel Advisors
Florida
+$9.62M
5
Goldman Sachs
Goldman Sachs
New York
+$9.02M

Top Sellers

1 -$18.1M
2 -$11.5M
3 -$7.83M
4
Prudential Financial
Prudential Financial
New Jersey
-$7.03M
5
Millennium Management
Millennium Management
New York
-$6.63M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$1.29M
77
$1.27M
78
$1.25M
79
$1.24M
80
$1.23M
81
$1.12M
82
$1.05M
83
$1.02M
84
$990K
85
$981K
86
$980K
87
$966K
88
$907K
89
$886K
90
$874K
91
$773K
92
$767K
93
$763K
94
$734K
95
$715K
96
$708K
97
$697K
98
$679K
99
$672K
100
$656K